spacer
home > ict > winter 2018 > promoting patterns
PUBLICATIONS
International Clinical Trials

Promoting Patterns

The clinical trial industry is transforming, and the vision for this is simple: embrace quality and automation across the clinical trial spectrum and move closer to zero-delay trials. Why? It provides better, faster results, offers more information for sponsors, allows more innovation for CROs, and, most importantly, presents expedited outcomes for patients in need. This transformation is just beginning and requires that we challenge ourselves, our teams, partners, and clients – the entire clinical trial industry – to work smarter and eliminate preventable delays.

Data Dilemmas

Drug or device trials are fundamentally science experiments. Everyone has some familiarity with how that works from those exciting high school or college labs where one measured some Newtonian physics principle. However, unlike those, in clinical trials, the outcome is unknown, and the data are never as crisp and predictable. For the most part, the signalto- noise ratio is exceedingly small. If the data collection or the analysis processes adds more noise to the system, the signal may become undetectable. When that happens, therapies that might have helped patients in need may never be approved because the data was not handled appropriately.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Abraham Gutman founded AG Mednet in 2005 and leads the company’s mission to improve, automate, and expedite outcomes in clinical trials by ensuring quality and compliance within drug, biologic, and device trials. Abraham holds a BA in computer science from Cornell University and an MSc in computer science from Yale University, US.
spacer
Abraham Gutman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Peli BioThermal Key Speakers at CTS Europe

Peli BioThermal, the global name in temperature controlled packaging, will highlight the rise of reusable temperature controlled packaging as guest speakers at Clinical Trial Supply Europe, being held in Milan on March 13 – 14, 2019.
More info >>

White Papers

pAVEway™ expression system for the efficient expression of therapeutic proteins

Fujifilm Diosynth Biotechnologies

One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement